TAF1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.607400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.911600E-01
Normal-vs-Stage2
5.562800E-01
Normal-vs-Stage3
2.978200E-01
Normal-vs-Stage4
8.001800E-01
Stage1-vs-Stage2
1.762570E-01
Stage1-vs-Stage3
3.200100E-03
Stage1-vs-Stage4
9.361600E-01
Stage2-vs-Stage3
4.708100E-02
Stage2-vs-Stage4
2.317800E-01
Stage3-vs-Stage4
6.369900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.666200E-01
Normal-vs-AfricanAmerican
5.656200E-01
Normal-vs-Asian
4.052800E-01
Caucasian-vs-AfricanAmerican
5.110800E-01
Caucasian-vs-Asian
9.117500E-02
AfricanAmerican-vs-Asian
1.181950E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.546200E-01
Normal-vs-Female
5.705200E-01
Male-vs-Female
7.811800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.205000E-01
Normal-vs-Age(41-60Yrs)
6.917000E-01
Normal-vs-Age(61-80Yrs)
5.070000E-01
Normal-vs-Age(81-100Yrs)
4.866800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.946800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.445200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.954380E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.035300E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.409900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.107600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.097400E-01
Normal-vs-Daily Drinker
2.279600E-01
Normal-vs-Weekly Drinker
4.799400E-01
Normal-vs-Occasional Drinker
6.632600E-01
Normal-vs-Social Drinker
4.858000E-01
Non Drinker-vs-Daily Drinker
7.304800E-01
Non Drinker-vs-Weekly Drinker
7.156400E-01
Non Drinker-vs-Occasional Drinker
1.426230E-01
Non Drinker-vs-Social Drinker
2.696800E-01
Daily Drinker-vs-Weekly Drinker
5.951600E-01
Daily Drinker-vs-Occasional Drinker
3.907000E-01
Daily Drinker-vs-Social Drinker
4.302800E-01
Weekly Drinker-vs-Occasional Drinker
1.589180E-01
Weekly Drinker-vs-Social Drinker
2.319600E-01
Occasional Drinker-vs-Social Drinker
9.410000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.758100E-02
Normal-vs-Grade 2
2.094000E-02
Normal-vs-Grade 3
1.010230E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.749600E-01
Grade 1-vs-Grade 3
7.846400E-01
Grade 1-vs-Grade 4
9.758100E-02
Grade 2-vs-Grade 3
4.868400E-01
Grade 2-vs-Grade 4
2.094000E-02
Grade 3-vs-Grade 4
1.010230E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.106400E-01
Normal-vs-NonDiabetic
5.430000E-01
Diabetic-vs-NonDiabetic
5.910800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.201600E-01
Normal-vs-NoPancreatitis
5.382000E-01
Pancreatitis-vs-NoPancreatitis
8.278600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.477000E-01
Normal-vs-N1
5.651000E-01
N0-vs-N1
7.634000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.949000E-01
Normal-vs-TP53-NonMutant
6.278600E-01
TP53-Mutant-vs-TP53-NonMutant
7.103600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
